E Fund Management’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $135K | Sell |
14,339
-2,492
| -15% | -$23.4K | 0.01% | 369 |
|
|
2025
Q1 | $120K | Sell |
16,831
-1,222
| -7% | -$8.69K | 0.01% | 379 |
|
|
2024
Q4 | $210K | Buy |
18,053
+1,634
| +10% | +$19.1K | 0.01% | 357 |
|
|
2024
Q3 | $337K | Buy |
16,419
+3,754
| +30% | +$77.1K | 0.02% | 239 |
|
|
2024
Q2 | $283K | Sell |
12,665
-1,795
| -12% | -$40.2K | 0.02% | 241 |
|
|
2024
Q1 | $398K | Sell |
14,460
-2,091
| -13% | -$57.5K | 0.02% | 222 |
|
|
2023
Q4 | $505K | Buy |
16,551
+4,476
| +37% | +$136K | 0.03% | 161 |
|
|
2023
Q3 | $382K | Buy |
12,075
+1,745
| +17% | +$55.2K | 0.03% | 174 |
|
|
2023
Q2 | $421K | Sell |
10,330
-452
| -4% | -$18.4K | 0.03% | 157 |
|
|
2023
Q1 | $402K | Sell |
10,782
-321
| -3% | -$12K | 0.03% | 165 |
|
|
2022
Q4 | $387K | Buy |
11,103
+3,710
| +50% | +$129K | 0.03% | 191 |
|
|
2022
Q3 | $414K | Sell |
7,393
-2,922
| -28% | -$164K | 0.04% | 173 |
|
|
2022
Q2 | $534K | Buy |
10,315
+5,938
| +136% | +$307K | 0.05% | 133 |
|
|
2022
Q1 | $318K | Buy |
+4,377
| New | +$318K | 0.01% | 181 |
|